Wirth MP - Search Results

1

Genomic Testing in Patients with Metastatic Castration-resistant Prostate Cancer: A Pragmatic Guide for Clinicians.

Merseburger AS, Waldron N, Ribal MJ, Heidenreich A, Perner S, Fizazi K, Sternberg CN, Mateo J, Wirth MP, Castro E, Olmos D, Petrylak DP, Chowdhury S. Merseburger AS, et al. Among authors: wirth mp. Eur Urol. 2021 Apr;79(4):519-529. doi: 10.1016/j.eururo.2020.12.039. Epub 2021 Jan 23. Eur Urol. 2021. PMID: 33494937 Review.

2

A review of studies of hormonal adjuvant therapy in prostate cancer.

Wirth M, Froehner M. Wirth M, et al. Eur Urol. 1999;36 Suppl 2:14-9. doi: 10.1159/000052338. Eur Urol. 1999. PMID: 10529561 Review.

3

Mucoepidermoid penile carcinoma: clinical, histologic, and immunohistochemical characterization of an uncommon neoplasm.

Froehner M, Schöbl R, Wirth MP. Froehner M, et al. Among authors: wirth mp. Urology. 2000 Jul 1;56(1):154. doi: 10.1016/s0090-4295(00)00530-6. Urology. 2000. PMID: 10869654

4

Is transurethral vaporesection of the prostate better than standard transurethral resection?

Helke C, Manseck A, Hakenberg OW, Wirth MP. Helke C, et al. Among authors: wirth mp. Eur Urol. 2001 May;39(5):551-7. doi: 10.1159/000052502. Eur Urol. 2001. PMID: 11464036 Clinical Trial.

5

Preoperative cardiopulmonary risk assessment as predictor of early noncancer and overall mortality after radical prostatectomy.

Froehner M, Koch R, Litz R, Oehlschlaeger S, Noack B, Manseck A, Albrecht DM, Wirth MP. Froehner M, et al. Among authors: wirth mp. Urology. 2003 Mar;61(3):596-600. doi: 10.1016/s0090-4295(02)02250-1. Urology. 2003. PMID: 12639654

6

Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancer.

Wirth MP, Weissbach L, Marx FJ, Heckl W, Jellinghaus W, Riedmiller H, Noack B, Hinke A, Froehner M. Wirth MP, et al. Eur Urol. 2004 Mar;45(3):267-70; discussion 270. doi: 10.1016/j.eururo.2003.10.013. Eur Urol. 2004. PMID: 15036669 Clinical Trial.

7

Comorbidity is poor predictor of survival in patients undergoing radical prostatectomy after 70 years of age.

Froehner M, Koch R, Litz RJ, Hakenberg OW, Oehlschlaeger S, Wirth MP. Froehner M, et al. Among authors: wirth mp. Urology. 2006 Sep;68(3):583-6. doi: 10.1016/j.urology.2006.03.050. Epub 2006 Sep 18. Urology. 2006. PMID: 16979740

8

Antiandrogens in the treatment of prostate cancer.

Wirth MP, Hakenberg OW, Froehner M. Wirth MP, et al. Eur Urol. 2007 Feb;51(2):306-13; discussion 314. doi: 10.1016/j.eururo.2006.08.043. Epub 2006 Sep 11. Eur Urol. 2007. PMID: 17007995 Review.

9

Advances in specific immunotherapy for prostate cancer.

Kiessling A, Füssel S, Wehner R, Bachmann M, Wirth MP, Rieber EP, Schmitz M. Kiessling A, et al. Among authors: wirth mp. Eur Urol. 2008 Apr;53(4):694-708. doi: 10.1016/j.eururo.2007.11.043. Epub 2007 Nov 26. Eur Urol. 2008. PMID: 18061335 Review.

10

Treatment of metastatic renal cell cancer with sunitinib during chronic hemodialysis.

Zastrow S, Froehner M, Platzek I, Novotny V, Wirth MP. Zastrow S, et al. Among authors: wirth mp. Urology. 2009 Apr;73(4):868-70. doi: 10.1016/j.urology.2008.10.028. Epub 2009 Jan 23. Urology. 2009. PMID: 19167044

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

463 results

Search Page

Filters